ATE227569T1 - Robustaflavon und dessen derivate als antivirales mittel - Google Patents

Robustaflavon und dessen derivate als antivirales mittel

Info

Publication number
ATE227569T1
ATE227569T1 AT96921740T AT96921740T ATE227569T1 AT E227569 T1 ATE227569 T1 AT E227569T1 AT 96921740 T AT96921740 T AT 96921740T AT 96921740 T AT96921740 T AT 96921740T AT E227569 T1 ATE227569 T1 AT E227569T1
Authority
AT
Austria
Prior art keywords
derivatives
robustaflavone
antiviral
biflavanoid
hsv
Prior art date
Application number
AT96921740T
Other languages
English (en)
Inventor
Yuh-Meei Lin
Michael T Flavin
Ralph Schure
David E Zembower
Geng-Xian Zhao
Original Assignee
Advanced Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Life Sciences Inc filed Critical Advanced Life Sciences Inc
Application granted granted Critical
Publication of ATE227569T1 publication Critical patent/ATE227569T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96921740T 1995-06-23 1996-06-21 Robustaflavon und dessen derivate als antivirales mittel ATE227569T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46595P 1995-06-23 1995-06-23
PCT/US1996/010718 WO1997000679A1 (en) 1995-06-23 1996-06-21 Biflavanoids and derivatives thereof as antiviral agents

Publications (1)

Publication Number Publication Date
ATE227569T1 true ATE227569T1 (de) 2002-11-15

Family

ID=21691631

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96921740T ATE227569T1 (de) 1995-06-23 1996-06-21 Robustaflavon und dessen derivate als antivirales mittel

Country Status (9)

Country Link
US (2) US5773462A (de)
EP (1) EP0833631B1 (de)
JP (1) JPH11508264A (de)
AT (1) ATE227569T1 (de)
AU (1) AU707798B2 (de)
CA (1) CA2225341A1 (de)
DE (1) DE69624813T2 (de)
MX (1) MX9710258A (de)
WO (1) WO1997000679A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE227569T1 (de) * 1995-06-23 2002-11-15 Advanced Life Sciences Inc Robustaflavon und dessen derivate als antivirales mittel
FR2755015B1 (fr) * 1996-10-25 1998-12-24 Sod Conseils Rech Applic Utilisation d'un extrait flavonoidique de ginkgo biloba substantiellement depourvu de terpenes, dans le domaine buccodentaire, et composition contenant un tel extrait
WO1998046238A1 (en) * 1997-04-15 1998-10-22 Medichem Research, Inc. Biflavinoids and derivatives thereof as antiviral agents, alone or in combination with at least one known antiviral agent
NZ519965A (en) * 1999-06-30 2004-03-26 Radak Systems Pty Ltd A spraying apparatus
US6677350B1 (en) 1999-09-22 2004-01-13 Advanced Life Sciences, Inc. Beta-fluoroethyl thiourea compounds and use
US6548241B1 (en) * 2000-11-28 2003-04-15 Gambro, Inc. Storage solution containing photosensitizer for inactivation of biological contaminants
KR20030037081A (ko) 2001-11-02 2003-05-12 한국과학기술연구원 Ｔ 타입 칼슘채널을 조절하여 복통을 억제하는 방법
US20070004649A1 (en) * 2003-02-25 2007-01-04 The Kitasato Institute Anti-influenza virus compound comprising biflavonoid-sialic acid glycoside
KR100647722B1 (ko) * 2004-02-18 2006-11-23 주식회사 바이오텍 아이 감기 예방용 조성물
PE20060503A1 (es) * 2004-08-26 2006-07-20 Wyeth Corp Prodroga de benzoxazoles substituidos como agentes estrogenicos
US9155792B2 (en) * 2006-02-13 2015-10-13 Trustees Of Boston University RecA inhibitors with antibiotic activity, compositions and methods of use
US20100234348A1 (en) * 2006-08-04 2010-09-16 Trustees Of Boston University Compositions and methods for potentiating antibiotic activity
US8314143B2 (en) * 2006-12-29 2012-11-20 Florida A&M University Synthetic flavonoids and pharmaceutical compositions and therapeutic methods of treatment of HIV infection and other pathologies
EP2674417A3 (de) * 2007-11-21 2014-04-09 Decode Genetics EHF Biaryl-PDE4-Inhibitoren zur Behandlung von Entzündungen
US9296717B2 (en) * 2009-08-19 2016-03-29 University Of The Free State Synthesis of C-3 coupled biflavonoids and C-3 coupled biflavonoid analogues
US9119814B2 (en) * 2009-10-14 2015-09-01 Woongjin Coway Co., Ltd. Composition for prevention of influenza viral infection comprising sumac extract, air filter comprising the same and air cleaning device comprising the filter
US20140348966A1 (en) * 2011-12-22 2014-11-27 Onesmo B. Balemba Garcinia buchananii baker compounds, compositions and related methods
CN107311973B (zh) * 2017-06-25 2021-04-06 石家庄学院 一种含硝酸酯基二氢杨梅素衍生物及其制备和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3544457A1 (de) * 1985-12-16 1987-06-19 Mape Establishment Arzneimittel zur behandlung von leberkrankheiten
JPS62200570A (ja) * 1986-02-27 1987-09-04 Fuji Photo Film Co Ltd 磁気記録再生装置
JPS6442426A (en) * 1987-08-11 1989-02-14 Daicel Chem Virus-genom inactivator
GB8728236D0 (en) * 1987-12-02 1988-01-06 Sandoz Ltd Improvements in/relating to fungicides
JPH01221314A (ja) * 1988-02-29 1989-09-04 Daicel Chem Ind Ltd ウイルス・ゲノム不活化剤
US5354866A (en) * 1989-05-23 1994-10-11 Abbott Laboratories Retroviral protease inhibiting compounds
IT1239281B (it) * 1989-10-27 1993-10-19 Indena Spa Composizioni per la riduzione dei depositi di grasso superfluo a base di principi attivi di origine vegetale ad attivita' agonista dell'adenilato ciclasi o/e ad attivita' antifosfodiesterasica
ATE227569T1 (de) * 1995-06-23 2002-11-15 Advanced Life Sciences Inc Robustaflavon und dessen derivate als antivirales mittel

Also Published As

Publication number Publication date
MX9710258A (es) 1998-08-30
AU707798B2 (en) 1999-07-22
JPH11508264A (ja) 1999-07-21
DE69624813T2 (de) 2003-09-11
WO1997000679A1 (en) 1997-01-09
DE69624813D1 (de) 2002-12-19
EP0833631B1 (de) 2002-11-13
US5773462A (en) 1998-06-30
AU6288096A (en) 1997-01-22
EP0833631A1 (de) 1998-04-08
CA2225341A1 (en) 1997-01-09
US5948918A (en) 1999-09-07

Similar Documents

Publication Publication Date Title
ATE227569T1 (de) Robustaflavon und dessen derivate als antivirales mittel
EA199901031A1 (ru) Производные бензимидазола
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
PH24870A (en) Pyrimidine nucleosides and their use in the treatment or prophylaxis of viral infection
ES2149267T3 (es) Carbonilos ciclicos substituidos y derivados de los mismos utiles como inhibidores de la proteasa retroviral.
HRP20050417B1 (hr) Antiviralni derivati nukleozida
DE69909756D1 (de) Antivirale pyrimidinderivate
BR9815166A (pt) "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral"
PT1280813E (pt) Analogos de nucleosidos de pirimidina antivirais
ATE211471T1 (de) Acridonderivate als antineoplastische-und antiretrovirale mittel
GEP20084377B (en) Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
DE69110528D1 (de) Chirale 2-(Phosphonomethoxy)propyl-Guanine als antivirale Agentien.
EP0594795A4 (de) Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren.
DE69731483D1 (de) Beta-l-dioxolanuridin-analoge zur behandlung und vorbeugung von durch ebv, vzv bzw. hv-8 verursachten viralen infektionen
EP1245230A3 (de) Amentoflavon als antivirales Mittel
ATE480238T1 (de) Analoge des 5(e)bromovinyluracils und verwandte pyrimidinnucleoside als antivirale mittel und verwendungsmethoden
ATE216399T1 (de) Verfahren zur inaktivierung von lipidumhüllten viren mit lipopeptiden und neue antivirale lipopeptide
FI943295A (fi) Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit
ES2062266T3 (es) Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas.
ECSP972314A (es) Derivados de aminoacidos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties